Multiple Myeloma Treatment in Turkey 2026: Complete Guide for US, UK, Canadian & Australian Patients — Costs, Clinics & Care

Multiple Myeloma Treatment in Istanbul: A Comprehensive Guide for 2026

Medical treatment costs in Turkey start from ,200 all-inclusive, saving patients 50–80% compared to Western (ISAPS 2023). Turkey has 30+ JCI-accredited facilities and hosted over 1.5 million medical tourists in 2024 (Turkish Ministry of Health, TÜİK SB-2024-018). MedTravelExpertise connects you with vetted, JCI-accredited partner hospitals offering competitive all-inclusive packages. This guide provides comprehensive information to help you make an informed decision about your medical journey to Turkey.

Cost Analysis: Unlocking Savings on Advanced Multiple Myeloma Care

The primary driver for many patients is the significant cost advantage. In 2026, treatment for multiple myeloma in Istanbul is projected to be 60-75% less expensive than in the USA and 40-50% less than in the UK, without compromising on quality. A typical cost breakdown looks like this: • CAR-T Cell Therapy: While costing upwards of $450,000 - $500,000 in the U.S., the same procedure in leading Istanbul centers is estimated to be between $90,000 - $120,000. • Targeted Therapy (e.g., Darzalex - daratumumab): A single cycle can cost over $15,000 in the U.S., whereas in Istanbul, the cost can be as low as $4,000 - $6,000. • Autologous Stem Cell Transplant (ASCT): The all-inclusive package price in Istanbul, including hospitalization and initial follow-ups, typically ranges from $45,000 - $65,000, compared to over $200,000 in the United States.

Leading JCI-Accredited Oncology Centers in Istanbul

When selecting a hospital, prioritize those with JCI accreditation and a dedicated, experienced hematology-oncology department. Leading institutions like the Acibadem Healthcare Group (particularly Acibadem Maslak Hospital), Memorial Healthcare Group (known for its Bone Marrow Transplant unit), and Anadolu Medical Center (in strategic partnership with Johns Hopkins Medicine) are at the forefront. These centers feature advanced BMT units, in-house capabilities for producing treatments like CAR-T cells, and comprehensive support services for international patients, including translators and logistical assistance.

Your treatment journey typically begins with a remote consultation, where you'll share your medical records for review by an Istanbul-based hematology-oncologist. Once a treatment plan is proposed and agreed upon, the clinic's international patient department will assist with all logistical arrangements. Expect to stay in Istanbul for several weeks to months, depending on your treatment protocol (e.g., a stem cell transplant requires a longer stay for engraftment and monitoring). Post-treatment follow-up can often be coordinated with your home-country oncologist, ensuring seamless continuity of care.